Capital flows, CMO moves, M&A. Eight editions a day, seven tiers, from the chopped neck.
ISABELLA'S ISLAYM&A IntelligenceNov 8, 7:02 AM EST
Marvell Technology is buying optical components maker Lumentum in a $115 billion all-stock deal to serve the growing market for AI data centers.
ReadingAI consolidation is moving upstream. Connectivity is now a strategic asset class, not a component. Optical makers outside this deal face margin compression within 18 months.
WatchThe next three optical acquirers will announce within 90 days. The independents will not wait.
HENRI IVM&A IntelligenceNov 8, 7:02 AM EST
Cinven / Theramex
· MSN ↗Private equity firm Cinven has agreed to acquire Theramex, the women's health pharmaceutical company, from Carlyle and PAI Partners for approximately £2.2 billion.
ReadingWomen's health pharma has moved from emerging category to consolidation target. Exit multiples are now PE-grade, not venture-grade. Founders in adjacent categories will watch the Cinven playbook for 12 months before asking for identical terms.
WatchCinven's next add-on acquisition in women's health pharma. Within six months. The strategy is clear.
MACALLAN 1926Capital MarketsNov 8, 7:02 AM EST
A group of Wall Street banks have been tapped to lead a $3.1 billion financing for private equity firm Clayton, Dubilier & Rice and McKesson Corp.'s acquisition.
ReadingHealthcare is the only category where leverage remained available in October. Sponsors bidding on non-healthcare assets now face higher funding costs or equity hurdles. The gap between healthcare and everything else widens.
WatchThe next two healthcare acquisitions announced by EQT and Blackstone. Both will be similarly overlevered. Both will close.
LOUIS XIIIExecutive AppointmentsNov 8, 7:02 AM EST
US activist investor Ananym Capital disclosed a stake in CTS Eventim KGaA in October 2026 and publicly argued the ticketing and live events group is significantly undervalued.
ReadingEuropean ticketing assets are back on the activist radar. CTS Eventim will either defend its independence or find a buyer before year-end. The November milestones will force a decision.
WatchCTS Eventim board response by November 15th. Follow the director appointments or the strategic review announcement.
PAPPY 23Capital MarketsNov 8, 7:02 AM EST
TTM Technologies / Churchill Downs / Terrestrial Energy
· MSN ↗TTM Technologies authorized a new $100 million repurchase program; Churchill Downs approved a $750 million program; Terrestrial Energy announced its own share repurchase program—all within the same window.
ReadingWhen PE deals slow, public companies de-lever and return cash. This is the canary. The boards know what sponsors will and will not pay.
WatchQ4 earnings calls will reveal how many buyback programs get halted or repriced downward if capital becomes tight.
JOHNNIE BLUELuxury SectorNov 8, 7:02 AM EST
Stocks for some of Europe's most famous luxury brands are plummeting to their lowest level in years as Chinese customers cut back purchases and an industry revaluation unfolds.
ReadingLuxury brand multiples are compressing toward heritage-brand levels, not growth-brand levels. Operators still planning for China rebounds in 2027 are working with old models.
WatchQ4 luxury earnings in November. Listen for China guidance. Watch for inventory mentions.
WELL POURCapital MarketsNov 8, 7:02 AM EST
PE Portfolio Delevering
· MSN ↗Private equity firms are increasingly using debt-funded dividend recaps to return cash to investors as exits remain subdued in the IPO and M&A markets.
ReadingDividend recaps are now the canary for sponsor conviction. High recaps = low exit confidence. Watch which sponsors use them most aggressively.
WatchThe first significant recap that fails to secure debt financing or requires higher spreads. That is your signal that lender appetite is shifting.
Leave catalogs to the libraries and archives. Join Brand101, the standard in brand identity → huanggoodman.com/brand-room